During the past decade, Mercy Medical Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Group" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Washington University School of Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Group" are "Arthroplasty, Replacement, Hip" (1 trials), "Electrical Dysfunction" (1 trials), "Externalized Conductors" (1 trials), "Relapsing Multiple Sclerosis" (1 trials) and "Ventricular Tachycardia" (1 trials). Many other conditions were trialed in "Mercy Medical Group" in a lesser frequency.

Most popular intervention types in "Mercy Medical Group" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads" (1 trials), "Interferon beta-1a" (1 trials), "Interferon beta-1a-matching placebo" (1 trials), "Ocrelizumab" (1 trials) and "Ocrelizumab-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Medical Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mercy Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".